FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Jarvis

Research Profile

Living Beings

Physiology

Chemicals & Drugs

Disorders

Cytomegalovirus Infections

Anatomy

Genes & Molecular Sequences

Devices

Bacterial Artificial Chromosomes

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Elena N Klyushnenkova; Diana V Kouiavskaia; Christopher J Parkins; Richard B Alexander; Sara Botto; Patrizia Caposio; Michael A Jarvis
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.
Scott G Hansen; Julia C Ford; Matthew S Lewis; Abigail B Ventura; Colette M Hughes; Lia Coyne-Johnson; Nathan Whizin; Kelli Oswald; Rebecca Shoemaker; Tonya Swanson; Alfred W Legasse; Maria J Chiuchiolo; Christopher L Parks; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Michael Piatak; Jeffrey D Lifson; Louis J Picker
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.
Scott G Hansen; Colin J Powers; Rebecca Richards; Abigail B Ventura; Julia C Ford; Don Siess; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Louis J Picker; Klaus J Frueh
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Jarvis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Elena N Klyushnenkova; Diana V Kouiavskaia; Christopher J Parkins; Richard B Alexander; Sara Botto; Patrizia Caposio; Michael A Jarvis
A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(5):390-9.
2011: Scott G Hansen; Julia C Ford; Matthew S Lewis; Abigail B Ventura; Colette M Hughes; Lia Coyne-Johnson; Nathan Whizin; Kelli Oswald; Rebecca Shoemaker; Tonya Swanson; Alfred W Legasse; Maria J Chiuchiolo; Christopher L Parks; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Michael Piatak; Jeffrey D Lifson; Louis J Picker
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.
Nature 2011;473(7348):523-7.
2010: Scott G Hansen; Colin J Powers; Rebecca Richards; Abigail B Ventura; Julia C Ford; Don Siess; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Louis J Picker; Klaus J Frueh
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.
Science (New York, N.Y.) 2010;328(5974):102-6.
2010: Paul T Wille; Amber J Knoche; Jay A Nelson; Michael A Jarvis; David C Johnson
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells.
Journal of virology 2010;84(5):2585-96.
2009: Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.
Nature medicine 2009;15(3):293-9.
2009: Bernadette M Dutia; Stuart J Reid; Derek D Drummond; Yvonne Ligertwood; Ian Bennet; Willard Rietberg; Ondine Silvia; Michael A Jarvis; Anthony A Nash
A novel Cre recombinase imaging system for tracking lymphotropic virus infection in vivo.
PloS one 2009;4(8):e6492.
2008: Brent J Ryckman; Barb L Rainish; Marie C Chase; Jamie A Borton; Jay A Nelson; Michael A Jarvis; David C Johnson
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells.
Journal of virology 2008;82(1):60-70.
2007: Michael A Jarvis; Jay A Nelson
Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal.
Journal of virology 2007;81(5):2095-101.
2006: Michael A Jarvis; Jamie A Borton; Amy M Keech; John Wong; William J Britt; Bruce E Magun; Jay A Nelson
Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation.
Journal of virology 2006;80(11):5588-98.
2006: Brent J Ryckman; Michael A Jarvis; Derek D Drummond; Jay A Nelson; David C Johnson
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion.
Journal of virology 2006;80(2):710-22.
2005: Nagendra R Hegde; Claire Dunn; David M Lewinsohn; Michael A Jarvis; Jay A Nelson; David C Johnson
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.
The Journal of experimental medicine 2005;202(8):1109-19.
2005: William J Britt; Michael A Jarvis; Derek D Drummond; Michael Mach
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
Journal of virology 2005;79(7):4066-79.
2004: Cary A Rue; Michael A Jarvis; Amber J Knoche; Heather L Meyers; Victor DeFilippis; Scott G Hansen; Markus Wagner; Klaus J Frueh; David G Anders; Scott W Wong; Peter A Barry; Jay A Nelson
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.
Journal of virology 2004;78(22):12529-36.
2004: William J Britt; Michael A Jarvis; Jun-Young Seo; Derek Drummond; Jay A Nelson
Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious virus.
Journal of virology 2004;78(1):539-43.
2004: Michael A Jarvis; Thomas R Jones; Derek D Drummond; Patsy P Smith; William J Britt; Jay A Nelson; Carl J Baldick
Phosphorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgi network and efficient virus replication.
Journal of virology 2004;78(1):285-93.
2003: Eain Murphy; Dong Yu; Jane Grimwood; Jeremy Schmutz; Mark Dickson; Michael A Jarvis; Gabriele Hahn; Jay A Nelson; Richard Myers; Thomas Shenk
Coding potential of laboratory and clinical strains of human cytomegalovirus.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):14976-81.
2002: Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus J Frueh
A functional genomics approach to Kaposi's sarcoma.
Annals of the New York Academy of Sciences 2002;975():180-91.
2002: Michael A Jarvis; Jay A Nelson
Human cytomegalovirus persistence and latency in endothelial cells and macrophages.
Current opinion in microbiology 2002;5(4):403-7.
2002: Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus J Frueh
Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.
Journal of virology 2002;76(16):8383-99.
2002: Michael A Jarvis; Jay A Nelson
Mechanisms of human cytomegalovirus persistence and latency.
Frontiers in bioscience : a journal and virtual library 2002;7():d1575-82.
2002: Michael A Jarvis; Kenneth N Fish; Cecilia Söderberg-Naucler; Daniel N Streblow; Heather L Meyers; Gary Thomas; Jay A Nelson
Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells.
Journal of virology 2002;76(10):5147-55.
2000: François Jean; Laurel Thomas; Sean S Molloy; G Liu; Michael A Jarvis; Jay A Nelson; Gary Thomas
A protein-based therapeutic for human cytomegalovirus infection.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2864-9.
2000: N J Leung; A Aldovini; R Young; Michael A Jarvis; JM Smith; D Meyer; David E Anderson; Maria P Carlos; Murray B Gardner; José V Torres
The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
Virology 2000;268(1):94-103.
1999: Michael A Jarvis; C E Wang; Heather L Meyers; Patsy P Smith; Christopher L Corless; G J Henderson; Jeffrey Vieira; William J Britt; Jay A Nelson
Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent.
Journal of virology 1999;73(6):4552-60.
1996: Linda G Levin; Michael A Jarvis; Jerry S Powell; J A Harrison; Howard Reisner
Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies.
Thrombosis and haemostasis 1996;76(6):998-1003.
1996: Michael A Jarvis; Linda G Levin; J A Harrison; Daryle Joseph Depianto; C M Suzuki; C L Ziaja; J E Brown; K W Jolly; Howard Reisner; C F Abildgaard; Jerry S Powell
Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Thrombosis and haemostasis 1996;75(2):318-25.